CS191274B2 - Process for preparing optically active or racemic derivatives of prost-5-en-13-inoic acid - Google Patents
Process for preparing optically active or racemic derivatives of prost-5-en-13-inoic acidInfo
- Publication number
- CS191274B2 CS191274B2 CS755872A CS587275A CS191274B2 CS 191274 B2 CS191274 B2 CS 191274B2 CS 755872 A CS755872 A CS 755872A CS 587275 A CS587275 A CS 587275A CS 191274 B2 CS191274 B2 CS 191274B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- prost
- optically active
- preparing optically
- inoic acid
- racemic derivatives
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2733374 | 1974-09-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS191274B2 true CS191274B2 (en) | 1979-06-29 |
Family
ID=11221442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS755872A CS191274B2 (en) | 1974-09-17 | 1975-08-28 | Process for preparing optically active or racemic derivatives of prost-5-en-13-inoic acid |
Country Status (20)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4220759A (en) * | 1975-03-14 | 1980-09-02 | Carlo Erba S.P.A. | 13,14-Dehydro-11-deoxy-prostaglandins and process for their preparation |
| HU178202B (en) * | 1977-09-26 | 1982-03-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing new,optically active and racemic bicyclic acetals and merkaptals |
| US20090287003A1 (en) * | 2005-09-29 | 2009-11-19 | Jiang Xing Chen | Process for the production of intermediates for making prostaglandin derivatives such as latanaprost, travaprost, and bimatoprost |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1425961A (en) * | 1972-04-13 | 1976-02-25 | Erba Carlo Spa | Prostanoic acid derivatives |
-
1975
- 1975-07-29 US US05/600,187 patent/US4041064A/en not_active Expired - Lifetime
- 1975-07-29 NO NO752675A patent/NO150117C/no unknown
- 1975-07-31 DK DK348575A patent/DK348575A/da not_active Application Discontinuation
- 1975-08-05 GB GB29939/77A patent/GB1514543A/en not_active Expired
- 1975-08-05 GB GB32731/75A patent/GB1514542A/en not_active Expired
- 1975-08-14 FI FI752303A patent/FI752303A/fi not_active Application Discontinuation
- 1975-08-15 JP JP50099416A patent/JPS5929075B2/ja not_active Expired
- 1975-08-19 ZA ZA755310A patent/ZA755310B/xx unknown
- 1975-08-22 DE DE19752537406 patent/DE2537406A1/de not_active Withdrawn
- 1975-08-28 NL NL7510191A patent/NL7510191A/xx not_active Application Discontinuation
- 1975-08-28 SU SU752163240A patent/SU942588A3/ru active
- 1975-08-28 CA CA234,430A patent/CA1098126A/en not_active Expired
- 1975-08-28 CS CS755872A patent/CS191274B2/cs unknown
- 1975-08-28 FR FR7526557A patent/FR2313028A1/fr active Granted
- 1975-08-29 SE SE7509607A patent/SE423992B/xx not_active IP Right Cessation
- 1975-08-29 BE BE159585A patent/BE832891A/xx not_active IP Right Cessation
- 1975-08-29 HU HU75EA151A patent/HU175345B/hu unknown
- 1975-09-01 IL IL48027A patent/IL48027A/xx unknown
- 1975-09-01 CH CH1126275A patent/CH614936A5/xx not_active IP Right Cessation
-
1978
- 1978-08-22 SE SE7808849A patent/SE427556B/sv not_active IP Right Cessation
-
1979
- 1979-01-18 HK HK40/79A patent/HK4079A/xx unknown
- 1979-08-16 CH CH752979A patent/CH617424A5/de not_active IP Right Cessation
-
1980
- 1980-12-30 MY MY16/80A patent/MY8000016A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG12063A (en) | Process for preparing of 16-oxygenated phosphanoic acid derivatives | |
| HU174102B (hu) | Sposob poluchenija novykh proizvodnykh 6-d-skobka-skobka zakryta-al'fa-amino-al'fa-skobka-p-acetoksi-fenil-acetamido-skobka zakryta-penam-3-karbonovojj kisloty s antibakterial'nojj aktivnost'ju | |
| CS188260B2 (en) | Process for preparing diethylestere of carbo-n-butoxyaldiminomethanphosphonic acid | |
| EG11847A (en) | Process for preparing of novel acid derivatives | |
| CS185578B2 (en) | Process for preparing derivatives of 13-thiaprostanic acid | |
| CS189642B2 (en) | Process for preparing derivatives of cephalosporic acid | |
| HU174848B (hu) | Sposob poluchenija novykh proizvodnykh 15,15-ehtilendioksi-prostanovoj kisloty | |
| HU171662B (hu) | Sposob poluchenija novykh, opticheski aktivnykh proizvodnykh apovinkaminola i ikh kislotnykh adduktov | |
| YU40262B (en) | Process for preparing racemic or optically active 4-substituted | |
| CS181798B2 (en) | Process for preparing derivatives of prostanic acid | |
| EG11933A (en) | Process for preparing of novel cyclopropancarboxylic acid esters | |
| CS191274B2 (en) | Process for preparing optically active or racemic derivatives of prost-5-en-13-inoic acid | |
| JPS51125042A (en) | Process for manufacture of 111epiiprostanic acid derivatives | |
| CS189009B2 (en) | Process for preparing esters of xanthen-9-carboxylic acid | |
| ZA752065B (en) | Process for the manufacture of salts of poly-alpha- hydroxyacrylic acid | |
| CH609971A5 (en) | Process for the preparation of prostanoic acid derivatives | |
| HU171908B (hu) | Sposob poluchenija proizvodnykh 5-sul'famoil-antranilovoj kisloty | |
| HU172246B (hu) | Sposob poluchenija solejj khlorouksusnojj kisloty | |
| CS191296B2 (en) | Process for preparing optically active or racemic fluorprostaglandine | |
| HU172484B (hu) | Sposob poluchenija 2-alkoksikarbonilamino-5/6/-fenil-sul'foniloksi-benzimidazolov s antgel'minticheskoj aktivnost'ju | |
| HU173223B (hu) | Sposob poluchenija proizvodnykh 9-okso-17-oksa-prostanovoj kisloty | |
| HU172524B (hu) | Sposob poluchenija novykh proizvodnykh acetil-salicil'noj kisloty | |
| CS193073B2 (en) | Process for preparing derivatives of 2-oxazolylcarbamic acid | |
| HU172291B (hu) | Sposob poluchenija proizvodnykh 2-gidroksimetil-tiazol-5-il-karbonovoj kisloty | |
| KR780000326B1 (en) | Process for preparation of optically active pantholactone |